UK markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
153.48+2.46 (+1.63%)
At close: 02:22PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close151.02
Open153.88
Bid0.00 x 0
Ask0.00 x 0
Day's range153.48 - 153.88
52-week range118.16 - 153.88
Volume515
Avg. volume4,406
Market cap238.649B
Beta (5Y monthly)0.19
PE ratio (TTM)37.90
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield2.86 (1.89%)
Ex-dividend date22 Feb 2024
1y target estN/A
  • Fool.co.uk

    £20,000 in cash? Here’s how I’d aim for £10,000 in annual passive income!

    Our writer explains how he'd maximise his investment allowance in a Stocks and Shares ISA to target £10k in tax-free passive income every year. The post £20,000 in cash? Here’s how I’d aim for £10,000 in annual passive income! appeared first on The Motley Fool UK.

  • Insider Monkey

    AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript

    AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript April 25, 2024 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.03 EPS, expectations were $1.22. AstraZeneca PLC isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning to those joining […]

  • Benzinga

    AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown

    European pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of Oxford, is facing a class action lawsuit alleging its vaccine caused death and serious injury in numerous cases. Lawyers representing the plaintiffs argue that the vaccine resulted in side effects for a small number of families, including brain injuries and fatalities. AstraZeneca, while contesting the claims, has acknowledged in court documents that its vaccine can, in rare instances, cause Thro